Stock Analysis on Net

UnitedHealth Group Inc. (NYSE:UNH)

$24.99

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
Quarterly Data

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Two-Component Disaggregation of ROE

UnitedHealth Group Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = ROA × Financial Leverage
Dec 31, 2025 = ×
Sep 30, 2025 = ×
Jun 30, 2025 = ×
Mar 31, 2025 = ×
Dec 31, 2024 = ×
Sep 30, 2024 = ×
Jun 30, 2024 = ×
Mar 31, 2024 = ×
Dec 31, 2023 = ×
Sep 30, 2023 = ×
Jun 30, 2023 = ×
Mar 31, 2023 = ×
Dec 31, 2022 = ×
Sep 30, 2022 = ×
Jun 30, 2022 = ×
Mar 31, 2022 = ×

Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The financial performance, as indicated by the provided metrics, demonstrates a period of initial stability followed by a notable shift in profitability and leverage. Return on Equity (ROE) initially exhibited an upward trajectory before experiencing a significant decline, while Financial Leverage fluctuated within a relatively constrained range. Return on Assets (ROA) mirrored the initial stability and subsequent decline observed in ROE.

Return on Equity (ROE)
ROE demonstrated consistent growth from March 31, 2022, peaking at 26.03% in September 2022, before stabilizing around 25.5% through December 2023. A substantial decrease is then observed, falling to 17.72% by March 31, 2024, and continuing to decline to 12.81% by December 31, 2025. This represents a significant erosion of shareholder returns over the latter portion of the analyzed period.
Financial Leverage
Financial Leverage showed a gradual increase from 3.04 in March 2022 to a peak of 3.49 in March 2023. It then experienced a moderate decline to 3.08 by December 2023, remaining relatively stable between 3.17 and 3.29 through December 2025. While fluctuations exist, the overall level of financial leverage remains consistent, suggesting that changes in ROE are not primarily driven by shifts in the company’s capital structure.
Return on Assets (ROA)
ROA followed a similar pattern to ROE, increasing from 7.89% in March 2022 to 8.19% in December 2022. A decline commenced in March 2023, reaching 5.40% by March 2024, and continuing downward to 3.89% by December 2025. This indicates a decreasing efficiency in utilizing assets to generate profit, contributing to the overall decline in ROE.

The disaggregation of ROE through these two components reveals that the decline in ROE is primarily attributable to the decreasing ROA, rather than a significant change in Financial Leverage. The relatively stable leverage suggests that the company’s asset base is becoming less productive in generating earnings. The period from March 2022 to December 2023 represents a period of relative strength, while the period from March 2024 to December 2025 indicates a weakening of financial performance.


Three-Component Disaggregation of ROE

UnitedHealth Group Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Dec 31, 2025 = × ×
Sep 30, 2025 = × ×
Jun 30, 2025 = × ×
Mar 31, 2025 = × ×
Dec 31, 2024 = × ×
Sep 30, 2024 = × ×
Jun 30, 2024 = × ×
Mar 31, 2024 = × ×
Dec 31, 2023 = × ×
Sep 30, 2023 = × ×
Jun 30, 2023 = × ×
Mar 31, 2023 = × ×
Dec 31, 2022 = × ×
Sep 30, 2022 = × ×
Jun 30, 2022 = × ×
Mar 31, 2022 = × ×

Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The three-component DuPont analysis reveals fluctuating performance metrics over the observed period. Return on Equity (ROE) demonstrated a peak in the third quarter of 2022 before experiencing a significant decline, followed by a partial recovery and subsequent decrease again. This fluctuation is attributable to changes in Net Profit Margin, Asset Turnover, and Financial Leverage.

Net Profit Margin
The Net Profit Margin exhibited an initial upward trend from March 2022 to December 2022, peaking at 6.25%. A substantial decrease is then observed, falling to 3.65% by December 2024. A partial recovery to 5.46% occurs in March 2025, but this is followed by a further decline to 2.72% by December 2025. This suggests increasing cost pressures or decreasing pricing power in recent periods.
Asset Turnover
Asset Turnover remained relatively stable between March 2022 and December 2022, fluctuating between 1.29 and 1.34. A decrease to 1.18 in March 2023 is noted, followed by a recovery and stabilization around 1.30-1.36 from June 2023 through September 2025. The final period shows an increase to 1.43, indicating improved efficiency in asset utilization.
Financial Leverage
Financial Leverage generally increased from March 2022 to September 2022, peaking at 3.26. A subsequent decrease to 3.08 occurred by December 2022, followed by a rise to 3.49 in March 2023. Leverage then decreased to 3.08 by December 2023, and has remained relatively stable between 3.17 and 3.29 through December 2025. This indicates a moderate level of financial risk, with some fluctuation in the use of debt financing.

The decline in ROE from 2022 to 2025 is primarily driven by the significant reduction in Net Profit Margin. While Asset Turnover shows some improvement in the later periods, and Financial Leverage remains relatively consistent, these factors have not been sufficient to offset the impact of the declining profitability. The most recent periods indicate a concerning trend of decreasing profitability, which warrants further investigation.

The period between March 2022 and December 2022 represents a period of peak performance, while the period from March 2024 to December 2025 demonstrates a clear deterioration in financial performance as measured by ROE and its components.


Five-Component Disaggregation of ROE

UnitedHealth Group Inc., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Financial Leverage
Dec 31, 2025 = × × × ×
Sep 30, 2025 = × × × ×
Jun 30, 2025 = × × × ×
Mar 31, 2025 = × × × ×
Dec 31, 2024 = × × × ×
Sep 30, 2024 = × × × ×
Jun 30, 2024 = × × × ×
Mar 31, 2024 = × × × ×
Dec 31, 2023 = × × × ×
Sep 30, 2023 = × × × ×
Jun 30, 2023 = × × × ×
Mar 31, 2023 = × × × ×
Dec 31, 2022 = × × × ×
Sep 30, 2022 = × × × ×
Jun 30, 2022 = × × × ×
Mar 31, 2022 = × × × ×

Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The five-component DuPont analysis reveals notable shifts in the drivers of return on equity over the observed period. Initially, from March 2022 through September 2022, return on equity exhibited an upward trajectory, peaking at 26.03%. Subsequently, a period of decline commenced, reaching a low of 12.81% by December 2025. This overall decrease in ROE appears to be primarily driven by changes in profitability and asset utilization, partially offset by adjustments in financial leverage.

Tax Burden
The tax burden remained relatively stable between March 2022 and December 2022, fluctuating between 0.78 and 0.79. A decrease was observed in March 2024 (0.73), followed by a slight recovery to 0.75 by December 2024. The tax burden then increased to 0.86 by December 2025, suggesting a potential impact from changes in tax regulations or income mix.
Interest Burden
The interest burden demonstrated a consistent, albeit gradual, decline from 0.93 in the first three quarters of 2022 to 0.78 in December 2025. This suggests improved management of debt financing or a reduction in overall debt levels, positively contributing to overall profitability.
EBIT Margin
The EBIT margin initially increased from 8.04% in March 2022 to 8.67% in December 2022, indicating strengthening operational efficiency. However, a significant decline began in March 2023, falling to 4.05% by December 2025. This substantial decrease in the EBIT margin is the most significant factor contributing to the overall decline in ROE, indicating potential pressures on revenue, increased costs, or a combination of both.
Asset Turnover
Asset turnover exhibited moderate fluctuations between 1.23 and 1.36 throughout the period. A slight decrease was observed from 1.33 in March 2022 to 1.32 in March 2024, followed by a more pronounced increase to 1.43 by December 2025. This suggests a late-period improvement in the efficiency of asset utilization, though not sufficient to offset the decline in profitability.
Financial Leverage
Financial leverage increased from 3.04 in March 2022 to a peak of 3.49 in March 2023, indicating increased reliance on debt financing. It then decreased to 3.08 by September 2022, and remained relatively stable between 3.17 and 3.29 through December 2024. A final decrease to 3.29 was observed in December 2025. While leverage initially amplified returns, its subsequent stabilization and slight decrease did not fully mitigate the impact of declining profitability on ROE.

In summary, the decline in return on equity is primarily attributable to the substantial reduction in the EBIT margin. While improvements in asset turnover and a decreasing interest burden provided some offsetting effects, they were insufficient to maintain the higher levels of ROE observed in the earlier part of the period. The increasing tax burden in the final period also contributed to the overall decline.


Two-Component Disaggregation of ROA

UnitedHealth Group Inc., decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Net Profit Margin × Asset Turnover
Dec 31, 2025 = ×
Sep 30, 2025 = ×
Jun 30, 2025 = ×
Mar 31, 2025 = ×
Dec 31, 2024 = ×
Sep 30, 2024 = ×
Jun 30, 2024 = ×
Mar 31, 2024 = ×
Dec 31, 2023 = ×
Sep 30, 2023 = ×
Jun 30, 2023 = ×
Mar 31, 2023 = ×
Dec 31, 2022 = ×
Sep 30, 2022 = ×
Jun 30, 2022 = ×
Mar 31, 2022 = ×

Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The financial performance, as indicated by the two-component disaggregation of Return on Assets (ROA), reveals notable shifts over the observed period. Initially, from March 31, 2022, through December 31, 2022, both Net Profit Margin and Asset Turnover demonstrated relative stability, contributing to a consistent ROA ranging from 7.89% to 8.19%. However, subsequent periods exhibit more pronounced fluctuations in both components, ultimately impacting overall ROA.

Net Profit Margin
The Net Profit Margin experienced a peak around 6.25% in late 2022 before initiating a substantial decline. This downward trend continued into the first half of 2024, reaching a low of 3.65% by September 30, 2024. A partial recovery is observed in the first half of 2025, increasing to 5.10%, but this remains significantly below the levels seen in 2022. The final quarter of 2025 shows a further decrease to 2.72%.
Asset Turnover
Asset Turnover remained relatively stable between 1.23 and 1.36 for most of the period, with a slight dip in the first half of 2023. A consistent upward trend is observed from September 30, 2024, culminating in a value of 1.43 by December 31, 2025. This suggests increasing efficiency in utilizing assets to generate revenue during the latter part of the analyzed timeframe.
Return on Assets (ROA)
The ROA generally mirrored the trends in Net Profit Margin, exhibiting a decline from 8.18% in December 2022 to 3.89% by December 2025. The initial stability in ROA during 2022 was a result of offsetting movements in the two components. The subsequent decrease in ROA is primarily driven by the significant reduction in Net Profit Margin, despite the increasing Asset Turnover in later periods. The increasing Asset Turnover partially mitigated the impact of the declining Net Profit Margin, but was insufficient to maintain the earlier ROA levels.

The interplay between Net Profit Margin and Asset Turnover demonstrates a shifting dynamic in profitability and efficiency. While asset utilization improved towards the end of the period, the substantial decline in profitability significantly impacted the overall Return on Assets. Further investigation into the factors driving the decrease in Net Profit Margin would be necessary to fully understand the underlying causes of this performance shift.


Four-Component Disaggregation of ROA

UnitedHealth Group Inc., decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover
Dec 31, 2025 = × × ×
Sep 30, 2025 = × × ×
Jun 30, 2025 = × × ×
Mar 31, 2025 = × × ×
Dec 31, 2024 = × × ×
Sep 30, 2024 = × × ×
Jun 30, 2024 = × × ×
Mar 31, 2024 = × × ×
Dec 31, 2023 = × × ×
Sep 30, 2023 = × × ×
Jun 30, 2023 = × × ×
Mar 31, 2023 = × × ×
Dec 31, 2022 = × × ×
Sep 30, 2022 = × × ×
Jun 30, 2022 = × × ×
Mar 31, 2022 = × × ×

Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The financial performance, as disaggregated through a four-component DuPont analysis, reveals notable shifts over the observed period. Return on Assets (ROA) experienced a decline from the initial period, with fluctuations throughout, before showing some signs of stabilization towards the end of the analyzed timeframe. This overall trend is attributable to changes in the underlying components of profitability and efficiency.

Tax Burden
The tax burden remained relatively stable between March 2022 and December 2023, consistently around 0.78 to 0.79. A noticeable increase is observed starting in March 2024, rising to 0.81 in March 2025 and peaking at 0.86 in December 2025. This suggests an increasing proportion of earnings are allocated to taxes in the later periods.
Interest Burden
The interest burden demonstrated a gradual decline from 0.93 in the first four quarters to 0.90 in September 2023. This trend continued into 2024, reaching 0.83 by December 2024. A more substantial decrease occurred in 2025, falling to 0.78 in December. This indicates a decreasing proportion of earnings are used to cover interest expenses, potentially due to debt reduction or refinancing at lower rates.
EBIT Margin
The EBIT margin initially exhibited an upward trend, increasing from 8.04% in March 2022 to 8.67% in December 2022. However, a significant decline commenced in March 2023, falling to 6.48% in March 2024 and continuing to 4.05% in December 2025. This substantial decrease in profitability is the primary driver of the overall ROA decline. A slight recovery is observed in March 2025 to 7.76% and June 2025 to 7.16%, but it does not offset the overall downward trajectory.
Asset Turnover
Asset turnover fluctuated between 1.18 and 1.36 throughout the period. A slight downward trend is visible from March 2022 (1.33) to September 2023 (1.26). However, the ratio increased in the latter part of the period, reaching 1.43 in December 2025, indicating improved efficiency in utilizing assets to generate revenue. While this increase partially offsets the impact of the declining EBIT margin, it is not sufficient to maintain the initial ROA levels.

The decline in ROA is primarily attributable to the significant reduction in the EBIT margin. While improvements in asset turnover and a decreasing interest burden provide some offsetting effects, they are insufficient to counteract the impact of lower profitability. The increasing tax burden in the later periods further contributes to the overall decline in ROA.


Disaggregation of Net Profit Margin

UnitedHealth Group Inc., decomposition of net profit margin ratio (quarterly data)

Microsoft Excel
Net Profit Margin = Tax Burden × Interest Burden × EBIT Margin
Dec 31, 2025 = × ×
Sep 30, 2025 = × ×
Jun 30, 2025 = × ×
Mar 31, 2025 = × ×
Dec 31, 2024 = × ×
Sep 30, 2024 = × ×
Jun 30, 2024 = × ×
Mar 31, 2024 = × ×
Dec 31, 2023 = × ×
Sep 30, 2023 = × ×
Jun 30, 2023 = × ×
Mar 31, 2023 = × ×
Dec 31, 2022 = × ×
Sep 30, 2022 = × ×
Jun 30, 2022 = × ×
Mar 31, 2022 = × ×

Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The financial performance, as indicated by the provided metrics, demonstrates notable shifts in profitability over the observed period. A consistent interplay between operating profitability, tax obligations, and interest expenses shapes the overall net profit margin. The analysis reveals a general decline in key profitability indicators from 2022 to 2025, though with some fluctuations.

Tax Burden
The tax burden remained relatively stable between March 2022 and December 2022, fluctuating around 0.79. A decreasing trend is observed from March 2023, reaching a low of 0.73 by March 2024, before increasing again to 0.86 by December 2025. This suggests a changing effective tax rate or adjustments in tax planning strategies.
Interest Burden
Similar to the tax burden, the interest burden exhibited stability between March 2022 and December 2022, consistently around 0.93. A gradual decline is apparent from March 2023, reaching 0.78 by December 2025. This decrease could be attributed to debt reduction, refinancing at lower rates, or a change in the company’s capital structure.
EBIT Margin
The EBIT margin showed an increasing trend from March 2022 to December 2022, peaking at 8.67%. A significant decline commenced in March 2023, with the margin falling to 4.05% by December 2025. This substantial decrease indicates a weakening in core operational profitability, potentially due to increased costs, pricing pressures, or reduced sales volume.
Net Profit Margin
The net profit margin mirrored the trend of the EBIT margin, starting at 5.91% in March 2022 and reaching 6.25% in December 2022. A pronounced downward trajectory began in March 2023, culminating in a net profit margin of 2.72% by December 2025. This decline, while influenced by the decreasing EBIT margin, is also moderated by the changes in tax and interest burdens. The decreasing tax burden partially offset the decline in EBIT margin in the earlier periods, but this effect diminished as the EBIT margin continued to fall.

The observed trends suggest a deterioration in overall profitability. While fluctuations in tax and interest burdens provide some cushioning, the primary driver of the declining net profit margin appears to be the significant reduction in the EBIT margin. Further investigation into the factors affecting operational efficiency and revenue generation is warranted.